fingolimod hydrochloride has been researched along with rada16-i in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (rada16-i) | Trials (rada16-i) | Recent Studies (post-2010) (rada16-i) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 90 | 1 | 78 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aligholi, H; Alipour, H; Azari, H; Mahdavipour, M; Mirzaei, E; Nami, M; Sarkoohi, P; Torabi, S; Zeraatpisheh, Z | 1 |
1 other study(ies) available for fingolimod hydrochloride and rada16-i
| Article | Year |
|---|---|
Local delivery of fingolimod through PLGA nanoparticles and PuraMatrix-embedded neural precursor cells promote motor function recovery and tissue repair in spinal cord injury.
Topics: Animals; Cell Differentiation; Fingolimod Hydrochloride; Glycols; Mice; Nanoparticles; Neural Stem Cells; Peptides; Recovery of Function; Spinal Cord Injuries | 2021 |